Generative AI statement The author(s) declared that generative AI was used in the creation of this manuscript
E., McClain, T., Carter, S
SLC25A22 promotes proliferation and survival of colorectal cancer cells with KRAS mutations and xenograft tumor progression in mice via intracellular synthesis of aspartate
BPC-157: Clinical Stagnation and Theoretical Oncological Risks To date, BPC-157 remains categorized as an experimental, unapproved substance with virtually no high-quality, peer-reviewed, randomized controlled trials (RCTs) demonstrating definitive safety and efficacy in human populations
Its available to people with insurance, Medicaid, Medicare, or Tricare, as long as they meet certain eligibility rules